Insider Trading History of Hochman David P

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hochman David P since 2015. This trader's CIK number is 1292834. At the time of last reporting, Hochman David P was the See Remarks of Orchestra Biomed Holdings, Inc.. (stock ticker symbol OBIO). Also see all insider trading activities at Orchestra Biomed Holdings, Inc..

Note that in the past Hochman David P also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Orchestra Biomed Holdings, Inc. (OBIO) by Hochman David P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 OBIO 26,000 $69,940 0 $0 0 $0
2024 OBIO 18,500 $94,060 0 $0 0 $0
2023 OBIO 0 $0 0 $0 41,394 $0

Yearly summary of insider trading at Search By Headlines.com Corp. (NAKD) by Hochman David P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 NAKD 10,000 $37,527 0 $0 0 $0
2015 NAKD 93,858 $84,274 0 $0 0 $0

Yearly summary of insider trading at Motus Gi Holdings, Inc. (MOTS) by Hochman David P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 MOTS 5,000 $4,965 0 $0 0 $0
2019 MOTS 10,000 $30,000 0 $0 0 $0
2018 MOTS 155,000 $708,800 0 $0 0 $0

Yearly summary of insider trading at Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Hochman David P

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 CRBP 2,000 $13,958 0 $0 0 $0
2018 CRBP 10,000 $60,700 0 $0 0 $0
2017 CRBP 18,400 $124,562 0 $0 0 $0
2016 CRBP 11,800 $76,746 0 $0 0 $0
2015 CRBP 1,000 $1,919 0 $0 60,000 $60,000


Insider trading activities at 4 companies by Hochman David P:

1. Orchestra Biomed Holdings, Inc. (OBIO)

2. Search By Headlines.com Corp. (NAKD)

3. Motus Gi Holdings, Inc. (MOTS)

4. Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Table 1. Insider trading of Orchestra Biomed Holdings, Inc. (OBIO) by Hochman David P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-21 OBIO Buy 6,000 2.49 14,940
2025-08-04 OBIO Buy 20,000 2.75 55,000
2024-12-18 OBIO Buy 5,000 4.91 24,550
2024-09-25 OBIO Buy 7,500 4.76 35,685
2024-09-24 OBIO Buy 2,500 4.91 12,275
2024-08-14 OBIO Buy 2,500 5.84 14,600
2024-06-25 OBIO Buy 1,000 6.95 6,950
2023-04-12 OBIO Option Ex 41,394 .00 0

Table 2. Insider trading of Search By Headlines.com Corp. (NAKD) by Hochman David P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-01-22 NAKD Buy 2,500 3.15 7,875
2016-01-06 NAKD Buy 600 3.90 2,340
2016-01-05 NAKD Buy 3,900 3.98 15,522
2015-12-30 NAKD Buy 3,000 3.93 11,790
2015-12-23 NAKD Buy 17,500 4.00 70,000
2015-12-10 NAKD Buy 1,358 3.00 4,074
2015-06-19 NAKD Buy 75,000 .14 10,200

Table 3. Insider trading of Motus Gi Holdings, Inc. (MOTS) by Hochman David P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-04 MOTS Buy 5,000 .99 4,965
2019-07-01 MOTS Buy 10,000 3.00 30,000
2018-12-24 MOTS Buy 20,000 2.70 54,000
2018-11-16 MOTS Buy 15,000 3.49 52,350
2018-05-17 MOTS Buy 5,000 5.49 27,450
2018-02-16 MOTS Buy 115,000 5.00 575,000

Table 4. Insider trading of Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Hochman David P

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-03-15 CRBP Buy 2,000 6.98 13,958
2018-05-14 CRBP Buy 5,000 5.47 27,375
2018-03-14 CRBP Buy 5,000 6.67 33,325
2017-11-15 CRBP Buy 5,000 6.55 32,750
2017-11-10 CRBP Buy 10,000 7.08 70,800
2017-05-11 CRBP Buy 3,400 6.18 21,012
2016-11-18 CRBP Buy 10,000 7.00 69,960
2016-08-22 CRBP Buy 1,800 3.77 6,786
2015-08-17 CRBP Buy 1,000 1.92 1,919
2015-06-12 CRBP Option Ex 60,000 1.00 60,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hochman David P (See Remarks of Orchestra Biomed Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.